Latest Articles and Analysis

Congenital syphilis has risen for 12 consecutive years — not because we lack a cure, but because the only approved treatment is in shortage, coverage is shrinking in the hardest-hit states, and immigration fear is keeping pregnant people away from the prenatal care where screening happens. The tools exist. The system keeps failing to deliver them.

Formulary cuts, fibrosis staging requirements making a comeback, and the near-disappearance of HCV charitable assistance programs — CANN's Q3 2026 HIV/HCV Co-Infection Watch maps a deteriorating access landscape for people living with HIV/HCV co-infection.

The HIV/HCV Co-Infection Watch is a project of the Community Access National Network (CANN) designed to research, monitor, and report on HIV and Hepatitis C (HCV) co-infection in the United States....

Congress has introduced the most ambitious federal hepatitis C elimination bill in a generation — $9.8 billion, no cost-sharing, and a delivery investment long overdue. The procurement model at its center could undermine the access it promises.

More than half of people living with HIV in the U.S. are now 50 or older—a public health success that demands more than good referral networks. Building HIV-inclusive aging organizations means developing real capacity before someone ever needs to be sent somewhere else.

For the first time, a finite course of therapy has produced a functional cure for chronic hepatitis B in large-scale phase 3 trials, but the communities carrying the heaviest burden of this disease are also the least likely to be screened, diagnosed, or insured. Whether this milestone translates into population-level progress is a policy question, not a scientific one.

The Centers for Disease Control and Prevention (CDC) released its National HIV Prevention and Care Objectives: 2026 Update on May 18, 2026, presenting the most recent national picture of the U.S. HIV...

On May 4, 2026, Health Secretary Robert F. Kennedy Jr. closed a daylong Make America Healthy Again (MAHA) Institute summit on mental health and overmedicalization by announcing a federal initiative...

On March 6, 2026, the Iowa Department of Health and Human Services filed a nine-page complaint in Polk County District Court alleging that NuCara Specialty Pharmacy failed to remit more than $22...

For a long time, I thought advocacy meant surviving the next appointment. I thought it meant learning how to explain my pain better, how to prepare for another referral visit, how to justify why I...

New Phase 3 data show a single-tablet regimen of bictegravir/lenacapavir could finally bring one-pill simplicity to long-term HIV survivors locked into complex regimens by decades of drug resistance. The science is closing the treatment gap. Will our policy systems do the same?

States are rationing HIV medications through prior auth and formulary cuts to solve ADAP budget crises — a strategy that costs more, drives resistance, and concentrates harm on the most vulnerable.

Florida ADAP cuts eligibility from 400% to 130% FPL, threatening 16,000 PLWHA.

HIV care system deterioration from administrative obstruction and funding delays presages catastrophic effects of potential budget cuts.

Federal policy changes including Medicaid work requirements and ADAP eligibility restrictions threaten access to HIV medications.

Impending HIV care crisis results from Medicaid work requirements, federal funding cuts, and healthcare system fragmentation.

Historical redlining policies correlate with current geographic disparities in HIV treatment access and care quality.

HHS budget proposal would eliminate critical HIV prevention funding and reduce Ryan White HIV/AIDS program resources.

Long-acting injectable HIV treatments demonstrate clinical promise but face coverage and implementation barriers.

Critical role of mental health services in HIV treatment and epidemic control.